PharmaBoardroom

Roche Fights off Biosimilar Competition to Grow 7% in 2018

Roche announced strong Group sales growth of seven percent for 2018, partly driven by the launch of MS blockbuster Ocrevus, which CEO Severin Schwan…

Xu Ting – Founder, Chairman and CEO, Alphamab Oncology,…

Dr Xu Ting, founder, chairman and CEO of Alphamab Oncology, shares his expert opinion on the recent regulatory and healthcare reforms in China, the…

Martin Dubuc – General Manager, Biogen France

Martin Dubuc, general manager of Biogen France, discusses the company’s strong leadership in neurosciences, its commitment to pioneering the…

Jack Wang – Founder & CEO, Biomobie, China

Jack Wang, founder and CEO of Biomobie, shares the inspirational story behind the establishment of the company, the regenerative principle driving the…

Yangzhou Wang – Chief Operations Officer, CrownBio, China

Dr Yangzhou Wang, chief operations officer of Crown Bioscience (CrownBio), shares the new era of development for the company following its acquisition…

Megatrends from the 2019 Deloitte Life Sciences Outlook

Deloitte's Global Life Sciences & Health Care industry leader, Greg Reh gives us an exclusive insight into their forecast for 2019's industry…

Korean Healthcare and Pharma’s 10-Year Plan

The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries…

Narihiko Yoshii – President, Mitsubishi Tanabe Pharma Korea

Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean patients by utilising legislation…

“Restricting Drug Patent Settlements is Bad for US…

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting…

Company Profile: Samsung BioLogics

It was less than a decade ago (2011) that Samsung BioLogics was a new kid on the block amongst Korea’s booming biotech conglomerates. Since then…

Young-Woo Park – CEO, Y-Biologics, South Korea

Young-Woo Park, CEO of Y-Biologics - renowned for their library with diversity of 1011 - unveils their plan to be the first in Korea to develop the…

Damaso Molero – General Manager, 3P Biopharmaceuticals,…

Damaso Molero, general manager of 3P Biopharmaceuticals, a leading Spanish CDMO, highlights the growth of the company and the need to continuously…

Tagged with BI